Dosimetric factors impacting urethral toxicity following stereotactic prostate radiotherapy

被引：0
|
作者：
Cardoso, Michael [1 ]
Richardson, Matthew [2 ]
Chlap, Phillip [1 ]
Keats, Sarah [1 ]
Glyde, Alan [3 ]
Arumugam, Sankar [1 ]
Pryor, David [3 ]
Bucci, Joseph [4 ]
Martin, Jarad [2 ]
Sidhom, Mark [1 ]
机构：
[1] Liverpool & Macarthur Canc Therapy Ctr, Radiat Oncol, Liverpool, Australia
[2] Calvary Mater, Radiat Oncol, Newcastle, NSW, Australia
[3] Princess Alexandra Hosp, Radiat Oncol, Brisbane, Qld, Australia
[4] St George Hosp, Canc Care Ctr, Radiat Oncol, Kogarah, NSW, Australia
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
Stereotactic; prostate; toxicity;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
636
引用
收藏
页码：S2343 / S2345
页数：4
相关论文
共 50 条
  • [31] Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy
    Devlin, Lynsey
    Dodds, David
    Sadozye, Azmat
    McLoone, Philip
    MacLeod, Nicholas
    Lamb, Carolynn
    Currie, Suzanne
    Thomson, Stefanie
    Duffton, Aileen
    BRITISH JOURNAL OF RADIOLOGY, 2020, 93 (1108):
  • [32] Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapy
    Kishan, Amar U.
    Park, Sang J.
    King, Christopher R.
    Roberts, Kristofer
    Kupelian, Patrick A.
    Steinberg, Michael L.
    Kamrava, Mitchell
    BRITISH JOURNAL OF RADIOLOGY, 2015, 88 (1056):
  • [33] Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy
    Eckl, Miriam
    Sarria, Gustavo R.
    Springer, Sandra
    Willam, Marvin
    Ruder, Arne M.
    Steil, Volker
    Ehmann, Michael
    Wenz, Frederik
    Fleckenstein, Jens
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [34] Dosimetric impact of hydrogel spacer use for stereotactic body radiotherapy of localised prostate cancer
    Ung, M.
    Bossi, A.
    Abbassi, L.
    Vautier, J.
    Anthonipillai, V
    Cheve, M.
    Blanchard, P.
    CANCER RADIOTHERAPIE, 2021, 25 (03): : 237 - 241
  • [35] Dosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate Cancer
    Seppala, Jan
    Suilamo, Sami
    Tenhunen, Mikko
    Sailas, Liisa
    Virsunen, Heli
    Kaleva, Erna
    Keyrilainen, Jani
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2017, 16 (02) : 238 - 245
  • [36] Dosimetric and radiobiological comparison of Cyberknife and Tomotherapy in stereotactic body radiotherapy for localized prostate cancer
    Chen, Chun-You
    Lee, Liang-Ming
    Yu, Hsiao-Wei
    Lee, Steve P.
    Lee, Hsin-Lun
    Lin, Yung-Wei
    Wen, Yu-Ching
    Chen, Yi-Ju
    Chen, Chiu-Ping
    Tsai, Jo-Ting
    JOURNAL OF X-RAY SCIENCE AND TECHNOLOGY, 2017, 25 (03) : 465 - 477
  • [37] Dosimetric impact of an endorectal balloon (ERB) in stereotactic body radiotherapy (SBRT) for prostate cancer
    Dubouloz, A.
    Zilli, T.
    Rouzaud, M.
    Miralbell, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (01) : 105 - 105
  • [38] Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy
    Miriam Eckl
    Gustavo R. Sarria
    Sandra Springer
    Marvin Willam
    Arne M. Ruder
    Volker Steil
    Michael Ehmann
    Frederik Wenz
    Jens Fleckenstein
    Radiation Oncology, 16
  • [39] Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy
    Jeffrey M. Ryckman
    Michael Baine
    Joseph Carmicheal
    Ferdinand Osayande
    Richard Sleightholm
    Kaeli Samson
    Dandan Zheng
    Weining Zhen
    Chi Lin
    Chi Zhang
    Radiation Oncology, 15
  • [40] Comment to "Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer"
    Chien, Yu-Tzu
    Kao, Yung-Shuo
    RADIOTHERAPY AND ONCOLOGY, 2023, 189
12345